Medgold Resources Corp.: Clarification of Technical Disclosure

Medgold Resources Corp. (TSX VENTURE:MED) announces that as a result of a review
by the British Columbia Securities Commission, it is issuing this news release
to clarify its technical disclosure. 


The Company previously published on its website under the "Portfolio" pages, in
a corporate presentation dated September 2013 (the "Corporate Presentation"), in
certain news releases issued in 2013, and in certain Management's Discussion and
Analysis filed in 2012 and 2013, descriptions of its properties located in
Portugal, Spain and Italy (collectively the "Property Disclosures"). Certain of
the technical information contained in the Property Disclosures was not
compliant with National Instrument 43-101 - Standards of Disclosure for Mineral
Projects ("NI 43-101"), as follows:




--  The Property Disclosures contained statements that the applicable
    property has multi-million ounce potential. Such statements are not
    compliant with NI 43-101 as they were not accompanied by the cautionary
    language required by NI 43-101 with respect to estimates of potential
    resources. 

--  In the Corporate Presentation, the Company discloses that it proposes to
    conduct at its Limarinho Prospect, Boticas Licence, Portugal trial
    mining with specific targets for tonnage and grades, as well as
    disclosing that the Company plans to perform a scoping study with
    specific targets for production rates and mine life. Such disclosures
    are not compliant with NI 43-101 as the Company has not yet calculated a
    mineral resource which would be required prior to doing a formal scoping
    study, and the disclosure omits to state that there is no guarantee that
    a mineral resource will be established, and the risks that trial mining
    of an exploration target will not be economic or successful. 

--  In the Corporate Presentation, on its website under the "Portfolio"
    pages, in certain of the Company's news releases issued in 2013, and in
    certain Management's Discussion and Analysis filed in 2012 and 2013, the
    Company summarizes certain exploration results by selectively reporting
    only the highest or best values. This type of disclosure is not
    compliant with NI 43-101 as it does not report the range of values
    obtained. 



The Company retracts the non-compliant statements and has removed them from the
Portfolio pages of its website. Please see our website for an updated
description of the Company's properties, as well as a revised corporate
presentation dated September 2013. 


Qualified Person 

Dr. Stewart D. Redwood, Consulting Geologist to the Company, is a Qualified
Person as defined by National Instrument 43-101 - Standards of Disclosure or
Mineral Projects. Dr. Redwood has reviewed and approved the technical
information contained in this news release. 


About Medgold

Medgold is aiming to become the leading Mediterranean-focused gold exploration
and project development company, with an extensive portfolio and pipeline of
projects across Portugal, Italy and Spain, targeting economically stressed, but
politically stable European countries that are seeking foreign investment to
invigorate the mining sector.


Additional information on Medgold can be found on the Company's website at
www.Medgoldresources.com and by reviewing the Company's page on SEDAR at
www.sedar.com.


ON BEHALF OF THE BOARD

Dan James, President

Neither the TSX Venture Exchange nor the Investment Industry Regulatory
Organization of Canada accepts responsibility for the adequacy or accuracy of
this release.


Forward-looking statements

This press release may contain forward-looking statements including, but not
limited to, comments regarding the timing and content of upcoming work programs,
geological interpretations, receipt of property titles, potential mineral
recovery processes, and other related matters. Forward-looking statements
address future events and conditions and therefore involve inherent risks and
uncertainties. Medgold's projects in Europe are at an early stage and all
estimates and projections are based on limited, and possibly incomplete, data.
More work is required before the mineralization and the projects' economic
aspects can be confidently modelled. Actual results may differ materially from
those currently anticipated in this news release. No representation or
prediction is intended as to the results of future work, nor can there be any
promise that the estimates and projections herein will be sustained in future
work or that the projects will otherwise prove to be economic.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Medgold Resources Corp.
Ralph Rushton (Vancouver)
Investor Relations
+1 604-801-5432
ralphr@goldgroup.com


Medgold Resources Corp.
Dan James (London)
President
+44 (0) 7972 579188
dj@medgoldresources.com
Medgold Resources (TSXV:MED)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024